Work

Initial Results from a Phase 2/3 Study of Recombinant Erwinia Asparaginase (JZP458) in Patients with Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) Who Are Allergic/Hypersensitive to E. coli-Derived Asparaginases

Year: 2021

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2021-147023

Authors: Luke Maese, Mignon L. Loh, Tong Lin, Etsuko Aoki, Michelle Zanette, Shirali Agarwal, Jeffrey A. Silverman, Mi Rim Choi, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau

Institutions: Huntsman Cancer Institute, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Jazz Pharmaceuticals (United States), Boston Children's Hospital, Dana-Farber Cancer Institute, NYU Langone Health, Baylor College of Medicine

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3213493703

Cites:

Cited by: 5

Related to: 10